These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Patent fight sparks biological warfare in the drug industry. Fortune; 2000 Jul; 142(3):40, 42. PubMed ID: 11066662 [No Abstract] [Full Text] [Related]
7. Biotech battle royale. Two firms fight over billion-dollar drug. Sherrid P US News World Rep; 2000 Mar; 128(11):52. PubMed ID: 10848209 [No Abstract] [Full Text] [Related]
8. Industrial health research in Canada. Morin Y CMAJ; 2007 Jun; 176(12):1734; author reply 1734. PubMed ID: 17548390 [No Abstract] [Full Text] [Related]
9. Sarbanes-Oxley rules to be relaxed? Lawrence S Nat Biotechnol; 2006 Jul; 24(7):731-2. PubMed ID: 16841042 [No Abstract] [Full Text] [Related]
10. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp]. Westerlund L Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544 [No Abstract] [Full Text] [Related]
11. Teva to acquire Chinese biogenerics manufacturer. Katsnelson A Nat Biotechnol; 2005 Jul; 23(7):765. PubMed ID: 16003343 [No Abstract] [Full Text] [Related]
12. Biotech firms concerned about drug pricing issues. Nagy K J Natl Cancer Inst; 1993 Dec; 85(24):1986-7. PubMed ID: 8246283 [No Abstract] [Full Text] [Related]